Abstract
Engaging in exploration and exploitation is essential to business survival and performance. While firms manage exploration and exploitation alliances for the long-term, how prepared are they for sudden shocks in the short-term? We address this question in the context of a unique and opportune natural experiment associated with the 2008 financial crisis. Our analysis of 155 new biopharmaceutical ventures over a seven-year period suggests that exploration alliances – with a long-term orientation – make a firm more vulnerable to external shocks. In contrast, exploitation alliances as well as a balance between exploration and exploitation alliances – which underlie short-term performance – enable the firm to sustain external shocks.
Original language | English |
---|---|
Pages (from-to) | 362-385 |
Number of pages | 24 |
Journal | Journal of Small Business Management |
Volume | 57 |
Issue number | 2 |
Early online date | 23 Feb 2017 |
DOIs | |
Publication status | Published - 1 Apr 2019 |
ASJC Scopus subject areas
- General Business,Management and Accounting
- Strategy and Management
- Management of Technology and Innovation
Fingerprint
Dive into the research topics of 'Alliances and survival of new biopharmaceutical ventures in the wake of the global financial crisis'. Together they form a unique fingerprint.Profiles
-
Dimo Dimov
- Management - Professor
- Strategy & Organisation
- Centre for Business, Organisations and Society (CBOS)
- Centre for Research in Entrepreneurship and Innovation at Bath
- EPSRC Centre for Doctoral Training in Cyber Security
- IAAPS: Propulsion and Mobility
- Centre for Future of Work
- Innovation Bridge
Person: Research & Teaching, Core staff, Affiliate staff